Back to top

Tale of the Tape

Zacks Equity Research

Questcor Pharmaceuticals (QCOR) Looks Good: Stock Surges 11.2% in Session
January 17, 2014


Trades from $3

Questcor Pharmaceuticals, Inc. was a big mover last session, as the company saw its shares rise a little over 11% on the day. This surge can be attributable to solid volume with far more shares changing hands than in a normal session. This broke the recent trend for the company, as the stock is now trading above the volatile price range of $50.19 to $55.44 in the past one-month time frame.

In the last 30 days, this biopharmaceutical company did not witness any estimate revisions and the Zacks Consensus Estimate has remained unchanged over the same period. However, the recent price action is encouraging, so make sure to keep a close watch on this firm in the near future.

Questcor Pharmaceuticals currently has a Zacks Rank #2 (Buy) while its Earnings ESP is 0.00%.

Some better-ranked stocks in the healthcare industry Actelion Ltd. (ALIOF - Free Report) , Gentium S.p.A and Affymetrix Inc. . All these stocks hold a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Actelion Ltd. (ALIOF) - free report >>